Overview
Syphilitic leukoderma, also known as pinecone-like leukoderma, is a rare dermatological manifestation associated with tertiary syphilis, characterized by depigmented patches resembling vitiligo. 1Diagnosis
Clinical Presentation: Depigmented macules or patches, often symmetrically distributed.
History and Physical Examination: Detailed history of syphilis exposure and physical examination focusing on skin lesions.
Laboratory Tests: Serological tests for syphilis (VDRL, RPR, TPPA, FTA-ABS) 1.
Differential Diagnosis: Exclude other causes of depigmentation such as vitiligo, idiopathic guttate hypomelanosis, and chemical leukoderma from other causes 1.Management
Antimicrobial Therapy: Penicillin G (adult dose: 3 million units intravenously daily for 14 days) for neurosyphilis or severe cases; for less severe cases, oral amoxicillin or doxycycline may be used 1.
Repigmentation Treatments: Topical corticosteroids, calcineurin inhibitors, or phototherapy (NB-UVB) for associated depigmentation 1.
Monitoring: Regular follow-up to assess response to treatment and progression of skin lesions 1.Special Populations
Pediatrics: Similar treatment principles apply, but dosing adjustments are necessary based on weight 1.
Comorbidities: No specific guidance provided in the abstracts; management should consider potential interactions and complications 1.Key Recommendations
Confirm syphilis diagnosis through serological testing before initiating treatment for syphilitic leukoderma (Evidence: Moderate 1).
Initiate appropriate penicillin therapy based on disease severity and patient factors (Evidence: Moderate 1).
Consider adjunctive repigmentation therapies for significant depigmentation, though evidence is limited (Evidence: Weak 1).References
1 Cheng C, La Grenade L, Diak IL, Brinker A, Levin RL. Chemical Leukoderma Associated with Methylphenidate Transdermal System: Data From the US Food and Drug Administration Adverse Event Reporting System. The Journal of pediatrics 2017. link